John Mascarenhas
John Mascarenhas
Explore linked clinical trials.3 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Revumenib in Patients With Myelofibrosis | Hemic and Lymphatic Diseases, Myeloproliferative Disorders, bone marrow disorder, hematologic disorder, primary myelofibrosis | Not yet recruiting | Phase 1 / Phase 2 | 2026-07-29 | NCT07734077 | |
| Study of Canakinumab in Patients With Myelofibrosis | Hemic and Lymphatic Diseases, Myeloproliferative Disorders, bone marrow disorder, hematologic disorder, primary myelofibrosis | Active, not recruiting | Phase 2 | 2026-05-07 | NCT05467800 | |
| Selinexor and Pacritinib in JAK Inhibitor-naïve MF Patients With Cytopenias | Cytopenia, Hemic and Lymphatic Diseases, Myeloproliferative Disorders, anemia, blood platelet disease, bone marrow disorder, hematologic disorder, primary myelofibrosis, thrombocytopenia | Not yet recruiting | Phase 2 | 2026-03-18 | NCT07447817 |